Skip to main content
OpenTrials
Completed

NCT Number: NCT03374371

Invasive Markers of Staphylococcus Epidermidis

The purpose of the study is to identify biomarkers allowing the distinction between invasive and non-invasive strains of Staphylococcus epidermidis. This distinction is important to determine if the patient is infected and, as a consequence, if an antibiotic treatment is required.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Hôpital Necker Enfants Malades

Paris, Île-de-France Region, 75015, France

About this study

In the hospital, a large proportion of bacteraemia and implantable medical device infections are caused by Staphylococcus epidermidis. This microorganism is the most abundant on human skin and all patients are carriers. Its remarkable ability to form biofilms on most materials explains that catheter-related infections are by far the most common.

S. epidermidis infections are difficult to treat because most strains are multi-resistant and antibiotics are less effective in the presence of biofilms.

In addition, S. epidermidis poses a major diagnostic problem because it is also the first source of contamination of blood culture sample and intraoperative samples (in case of suspected infection of orthopedic material in particular). Thus, when a sample is positive for S. epidermidis, there is less than a 25% chance that it reflects true bacteremia in the patient and 30% of patients would inappropriately receive vancomycin following contaminated blood cultures. Differentiating a contamination of a blood or intraoperative sample from true S. epidermidis infection is therefore crucial for patient management because unnecessary antibiotic therapy is potentially responsible for the emergence of resistant strains, toxicity and additional costs.

The objective of this study is to identify the genetic markers that make it possible to differentiate the strains causing infections from the strains causing contamination by comparing their genomes using high throughput sequencing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

CASE Inclusion Criteria:

Population 1: nosocomial bacteraemia associated with intravascular devices

  • Hospitalized patient with intravascular device (peripheral or central, venous or arterial, short or long duration) for at least 48 hours before the development of bacteraemia
  • Presenting a definite infection with S. epidermidis according to the categorization criteria,

Sub-Population 1A:

3a) Aged less than 28 days (New-born)

Sub-population 1B:

3b) Aged 28 days or more

Population 2: nosocomial infections of implanted material

  • An operated patient carrying implanted equipment following orthopaedic surgery, following cardiac surgery or following neurosurgery,
  • Presenting a definite infection with S. epidermidis according to the categorization criteria occurring in the year following surgery

CONTROL Inclusion Criteria:

Population 1: carrier of intravascular devices

  • Hospitalized patient with intravascular device (peripheral or central, venous or arterial, short or long duration) for at least 48 hours before positive blood culture with S. epidermidis
  • Certain contamination with S. epidermidis according to the categorization criteria,

Sub-Population 1A:

3a) Aged less than 28 days (Newborn)

Sub-population 1B:

3b) Aged 28 days or more

Population 2: carrier of implanted material

  • An operated patient carrying implanted equipment following orthopedic surgery, following cardiac surgery or following neurosurgery,
  • Presenting a certain contamination to S. epidermidis according to the categorization criteria occurring in the year following surgery

Exclusion criteria

CASE Exclusion Criteria Population 1: nosocomial bacteremia associated with intravascular devices

  • Opposition of the patient or the holders of parental authority (minor patients)
  • Patient with polymicrobial infection
  • Patient with a colonized catheter (positive catheter end culture <103UFC / mL) with no clinical signs of local or general infection and with sterile peripheral blood cultures
  • Patient with local catheter infection (positive catheter end culture> 103UFC / mL) with local inflammatory signs only and with sterile peripheral blood cultures

Population 2: nosocomial infections of implanted material

  • Opposition of the patient or the holders of parental authority (minor patients)
  • Patient with an infection of material concomitant with a catheter-related infection

CONTROL Exclusion Criteria

Populations 1 and 2:

Opposition of the patient or the holders of parental authority (minor patients)

Treatment and study plan

high-throughput sequencing

Diagnostic Test

technique of high-throughput sequencing of the markers present in the genome of the S. epidermidis strains responsible for infection in order to help to discriminate the true infections of the contaminations

Primary outcomes

  1. genetic markers of S. epidermidis

    Time frame: at the time of the positive sampling of S. epidermidis

    to identify genetic markers associated with a significant risk of invasive S. epidermidis infections

Secondary outcomes

  1. Correlation of the genotype with the characteristics of the infections

    Time frame: at the time of the positive sampling of S. epidermidis

    identification of genetic markers specifically associated with a type of infection (catheter-related bacteremia in newborns, catheter-related bacteremia in patients 28 days or older, infections of orthopedic equipment or infections of cardiac equipment)

  2. Intra-hospital cross-transmission detection

    Time frame: at the time of the positive sampling of S. Epidermidis

    The comparison of the strains will be based on the study of the variations in the part of the genome that is common to all the strains to detect possible transfers between patients

Sponsors and collaborators

Lead sponsor

Assistance Publique - Hôpitaux de Paris

Other

Collaborators

  • URC-CIC Paris Descartes Necker Cochin

Registry information

Official study title

Identification of Genomic Markers Associated With the Invasiveness of Staphylococcus Epidermidis Strains Responsible for Infections

Acronym: SepiNGS

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Dec 15, 2017
Registry last updated
Jan 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.